QWO FDA approval date

The FDA approved QWO on 6 Jul 2020.

FDA approval date
6 Jul 2020

Drug identity has not yet been verified against registry records

Also recorded as COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-07-06DayQWOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761146", "applicant_as_listed_by_fda": "ENDO GLOBAL AESTHETICS LTD", "brand_names": ["QWO"], "active_ingredients": ["COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200706", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026